본문 바로가기

Research Performance

In 2015 Asia's first clinical study of Embryonic stem cells, retinal cell therapy published.
The world's first the success rate of cloned stem cells dramatically increased.

Product Indication F&D Pre-Clinical Phase Note
Embryonic Stem Cells Pipelines
Retinal Pigment
Epithelial Cells
Stargardt's Macular
Dystrophy (SMD)
Technology transfer & 
Partnership with US
Ocata Therapeutics, Inc.
Age-related Macular
Degeneration (AMD)
Myopic Macular
Degeneration (MMD)
Adult Stem Cells or Somatic Cells Pipelines
Placental Adherent
Stromal Cells (PLX-PAD)
Claudication (IC)
Technology transfer &
Partnership with Israel
Pluristem Therapeutics, Inc.
Umbilical Cord-derived
Stem Cells (CB-AC-01)
Acute Cerebral
Disk Degeneration
Mescenchymal Stem
Cells (CB-AC-02)
Alzheimer's Disease
Global Cerebral Ischemia Investigator Initiated Trial
Traumatic Optic Nerve Investigator Initiated Trial
Stem Cells 
Articular Cartilage Injury Investigator Initiated Trial
Disk Degeneration Investigator Initiated Trial
Rheumatoid Arthritis
Diabetes mellitus
Neural Progenitor Cells Parkinson's Disease Investigator Initiated Trial
Immunocytes Recurrent Glioblastoma Investigator Initiated Trial
ovarian cancer Investigator Initiated Trial
liver cancer Investigator Initiated Trial
Dendritic Cells
Division Contents
Embryonic-derived stem cell Apply embryonic-derived stem cells for various indications by differentiating them to retinal pigment epithelium (RPE) Differentiation to various stem cells including embryonic-derived stem cells, culturing methods, and pharmaceutical composite materials.
Placenta-derived stem cell Separation, culture, and pharmaceutical usage of placenta-derived mesenchymal stem cells for various indications
Umbilical cord-derived stem cell Separation, culture, and pharmaceutical usage of umbilical cord-derived stem cells for various indications
Cord blood Agents including cord blood or cord blood-derived stem cells and its pharmaceutical usage for various indications
Fat-derived stem cell Separation, culture, and pharmaceutical usage of fat-derived stem cells for various indications
Testis-derived stem cell Testis-derived pluripotent stem cell manufacturing methods and its pharmaceutical usage for various indications
Induced pluripotent stem cell
Induced pluripotent stem cell methods, associated pharmaceutical composite materials, and screening methods
Immunocyte Natural killer cell, dendritic cell, or T lymphocyte manufacturing methods and its pharmaceutical usage for various indications including cancer
Stem cell bank The stem cell bank operation system and its usage
Platform technology Drug screening using stem cells, customized diet suggestion system, and screening system for embryonic stem cell culture
Cosmetics Culture fluid originated from various tissues or cells, such as placenta-derived or stem cell-derived ingredients, and cosmetics composite materials including active ingredients
Cell extract Centrifugation bags, separation devices, etc. for extracting SVF (Stromal Vascular Fraction) or stem cells
Num. Title Author Journal names Date
848 Diagnostic performances and interobserver agreement according to observer experience: a comparison study using three guidelines for management of thyroid nodules Ko JE and 6 others Acta radiologica Nov-2017
847 Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study Choi SA, Kim MJ, Lee HJ, Kim JY, Jang EM, Kim JW, Park HM, Ryu SU, Lee US, Yoon TK, Kim YS Archives of Gynecology and Obstetrics Dec-2017
846 The Practice Patterns and Perceptions of Korean Surgeons Regarding Margin Status after Breast-Conserving Surgery Kim SK and 12 others Journal of Breast cancer Dec-2017
845 A novel mouse model of atopic dermatitis that is T helper 2 (Th2)-polarized by an epicutaneous allergen Choi YS and 7 others Environmental Toxicology and Pharmacology Dec-2017
844 Intestinal P-glycoprotein inhibitors, benzoxanthone analogues Na YH and 5 others Journal of pharmacy and pharmacology Dec-2017
843 Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy Kim OJ and 17 others SEIZURE-EUROPEAN JOURNAL OF EPILEPSY Dec-2017
842 Estimating the impact of a television campaign on tuberculosis knowledge and intention to test for TB in South Korea Oh HJ and 2 others International Journal of Tuberculosis and Lung Disease Dec-2017
841 Evaluation of predictive factors of vertebral compression fracture after conventional palliative radiotherapy for spinal metastasis from colorectal cancer Jang SK and 4 others Journal of Neurosurgery: Spine Dec-2017
840 Hepcidin and DNA promoter methylation in hepatocellular carcinoma Choi SW and 16 others European journal of clinical investigation Dec-2017
839 Clinical characterization of unknown/cryptogenic status epilepticus suspected as encephalitis: A multicenter cohort study Sin JW and 19 others Journal of Neuroimmunology Dec-2017
첫 페이지로 이동 이전 페이지로 이동 1 2 3 4 5 다음 페이지로 이동 마지막 페이지로 이동

Adipose Stem Cells

Adipose Stem Cells can be easily extracted with liposuction. They are ideal stem cells for the regenerative medicine due to the fact that a large amount of stem cells can be obtained from a relatively small amount of adipose tissues. They have been mainly only used for wrinkle improvement and cosmetic surgeries ; however, they are now widely applied to treat various diseases such as myocardial infarction, diabetes, liver ailment, ischemic peripheral circulatory disorders, urinary incontinence as numerous research outcomes proved that these cells have plenty of mesenchymal stem cells, which are helpful for cell restoration.

Patient - Harvest fat tissues - Adipose tissue(lipoaspirate) - RBC wash or lysis - Well mix with collagenase in shaking incubator - 1st centrifugation for SVF - 2nd centrifugation with N/S then pipette out N/S to wash out ollagenase, 2 times more Harvest thick pellet at bottom - Differentiate Adult Stem Cell - Fat, Bone, Muscle, Cartilage - Injection with fine tube as 1cc in every 1 minute after shaking well the syringe
Definition of SVF Therapy

Adipose tissues are major sources for stem cells.
SVF (Stromal Vascular Fraction) is defined as a therapy to inject stem cells intravenously, and the stem cells (2 to 5x106 units) are safely harvested with the medical instrument from adipose tissues obtained by conducting liposuction on the abdominal region.

Effects of SVF Therapy

The main purpose is the regeneration of stem cells.
In addition, it has a good effect on recovering chronic fatigue and preventing aging as it helps to form abundant growth factors as well as anti-inflammatory factors. Furthermore, there have been many patients who testified that they experienced the improvement of eyesight, erectile function, hair growth.

SVF Programs

Injection to Face To boost forming new blood vessels and collagens with the purpose to improve skin elasticity.
Intra-Venous Injection To improve clinical symptoms relevant to aging with the purpose to have an Anti-Aging effect.
Injection to Joint cartilage In order to reduce inflammation and pain, regenerate the articular cartilage.

Cord blood stem cells are used therapeutically in transplants to help cure, treat and repair damaged blood and immune systems.
Cord blood stem cells are being studied for potential use in regenerative medicine. CHA has been applying the stem cells to Cerebral Palsy patients since 2009 and developing pipeline for Stroke and Alzheimer's. Chaum provides opportunity to participate in the clinical trial for Cord Blood. We expect that this will help stimulate and guide the body's own repair system to heal damaged tissue and organs without any side effects.

Benefits of Cord Blood Clinical Trial

  • Cord Blood has abundant growth factors.
  • Cord Blood has excellent capabilities of differentiation
  • It's clearly proven that there is no adverse effect of transplanting cord blood.
  • CHA Health Systems Group's Cord Blood Bank has total 900 transplanting cases)

Cord Blood Stem Cell Collection & Transplant Process

Cord Blood Bank, ICORD

Cord blood transplant clinical status

It is ongoing to "Randomized, double-blind, placebo-controlled and pre-clinical studies for the potential efficacy and safety about improving clinical aging indicators by injection of Umbilical cord blood or plasma to adults in previous step of decrepitude" approved by the IRB.

Approximately 53% of the participants 84 (including during clinical studies with placebo) until now seemed to improve in the next part.